These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
186 related articles for article (PubMed ID: 26214194)
1. Targeted delivery of a novel anticancer compound anisomelic acid using chitosan-coated porous silica nanorods for enhancing the apoptotic effect. Senthilkumar R; Karaman DŞ; Paul P; Björk EM; Odén M; Eriksson JE; Rosenholm JM Biomater Sci; 2015 Jan; 3(1):103-11. PubMed ID: 26214194 [TBL] [Abstract][Full Text] [Related]
2. Integrated hollow mesoporous silica nanoparticles for target drug/siRNA co-delivery. Ma X; Zhao Y; Ng KW; Zhao Y Chemistry; 2013 Nov; 19(46):15593-603. PubMed ID: 24123533 [TBL] [Abstract][Full Text] [Related]
3. Dual-Targeting Multifuntional Mesoporous Silica Nanocarrier for Codelivery of siRNA and Ursolic Acid to Folate Receptor Overexpressing Cancer Cells. Zheng G; Shen Y; Zhao R; Chen F; Zhang Y; Xu A; Shao J J Agric Food Chem; 2017 Aug; 65(32):6904-6911. PubMed ID: 28771340 [TBL] [Abstract][Full Text] [Related]
4. Cancer-targeted and intracellular delivery of Bcl-2-converting peptide with functional macroporous silica nanoparticles for biosafe treatment. Wu Y; Ge P; Xu W; Li M; Kang Q; Zhang X; Xie J Mater Sci Eng C Mater Biol Appl; 2020 Mar; 108():110386. PubMed ID: 31923940 [TBL] [Abstract][Full Text] [Related]
5. Carboxymethyl-β-cyclodextrin conjugated nanoparticles facilitate therapy for folate receptor-positive tumor with the mediation of folic acid. Su C; Li H; Shi Y; Wang G; Liu L; Zhao L; Su R Int J Pharm; 2014 Oct; 474(1-2):202-11. PubMed ID: 25149123 [TBL] [Abstract][Full Text] [Related]
6. Redox-responsive nanocarriers for drug and gene co-delivery based on chitosan derivatives modified mesoporous silica nanoparticles. Lin JT; Liu ZK; Zhu QL; Rong XH; Liang CL; Wang J; Ma D; Sun J; Wang GH Colloids Surf B Biointerfaces; 2017 Jul; 155():41-50. PubMed ID: 28407530 [TBL] [Abstract][Full Text] [Related]
7. Folate-conjugated hybrid SBA-15 particles for targeted anticancer drug delivery. Pang J; Zhao L; Zhang L; Li Z; Luan Y J Colloid Interface Sci; 2013 Apr; 395():31-9. PubMed ID: 23312579 [TBL] [Abstract][Full Text] [Related]
8. Ultrasound-Triggered Destruction of Folate-Functionalized Mesoporous Silica Nanoparticle-Loaded Microbubble for Targeted Tumor Therapy. Lv Y; Cao Y; Li P; Liu J; Chen H; Hu W; Zhang L Adv Healthc Mater; 2017 Sep; 6(18):. PubMed ID: 28671341 [TBL] [Abstract][Full Text] [Related]
9. Targeted anticancer prodrug with mesoporous silica nanoparticles as vehicles. Fan J; Fang G; Wang X; Zeng F; Xiang Y; Wu S Nanotechnology; 2011 Nov; 22(45):455102. PubMed ID: 22019849 [TBL] [Abstract][Full Text] [Related]
10. The intracellular controlled release from bioresponsive mesoporous silica with folate as both targeting and capping agent. Guo R; Li LL; Zhao WH; Chen YX; Wang XZ; Fang CJ; Feng W; Zhang TL; Ma X; Lu M; Peng SQ; Yan CH Nanoscale; 2012 Jun; 4(11):3577-83. PubMed ID: 22543578 [TBL] [Abstract][Full Text] [Related]
11. Folic acid-conjugated iron oxide porous nanorods loaded with doxorubicin for targeted drug delivery. Yu P; Xia XM; Wu M; Cui C; Zhang Y; Liu L; Wu B; Wang CX; Zhang LJ; Zhou X; Zhuo RX; Huang SW Colloids Surf B Biointerfaces; 2014 Aug; 120():142-51. PubMed ID: 24907583 [TBL] [Abstract][Full Text] [Related]
12. Folic acid-conjugated chitosan oligosaccharide-magnetic halloysite nanotubes as a delivery system for camptothecin. Dramou P; Fizir M; Taleb A; Itatahine A; Dahiru NS; Mehdi YA; Wei L; Zhang J; He H Carbohydr Polym; 2018 Oct; 197():117-127. PubMed ID: 30007596 [TBL] [Abstract][Full Text] [Related]
13. Targeted anticancer potential against glioma cells of thymoquinone delivered by mesoporous silica core-shell nanoformulations with pH-dependent release. Shahein SA; Aboul-Enein AM; Higazy IM; Abou-Elella F; Lojkowski W; Ahmed ER; Mousa SA; AbouAitah K Int J Nanomedicine; 2019; 14():5503-5526. PubMed ID: 31410001 [TBL] [Abstract][Full Text] [Related]
15. Caspase 3 Targeted Cargo Delivery in Apoptotic Cells Using Capped Mesoporous Silica Nanoparticles. de la Torre C; Mondragón L; Coll C; García-Fernández A; Sancenón F; Martínez-Máñez R; Amorós P; Pérez-Payá E; Orzáez M Chemistry; 2015 Oct; 21(44):15506-10. PubMed ID: 26493876 [TBL] [Abstract][Full Text] [Related]
16. Doxorubicin loaded silica nanorattles actively seek tumors with improved anti-tumor effects. Gao F; Li L; Liu T; Hao N; Liu H; Tan L; Li H; Huang X; Peng B; Yan C; Yang L; Wu X; Chen D; Tang F Nanoscale; 2012 Jun; 4(11):3365-72. PubMed ID: 22538830 [TBL] [Abstract][Full Text] [Related]
17. Targeted delivery of adenosine 5'-triphosphate using chitosan-coated mesoporous hydroxyapatite: A theranostic pH-sensitive nanoplatform with enhanced anti-cancer effect. Feiz MS; Meshkini A Int J Biol Macromol; 2019 May; 129():1090-1102. PubMed ID: 30170062 [TBL] [Abstract][Full Text] [Related]
18. Folic acid (FA)-conjugated mesoporous silica nanoparticles combined with MRP-1 siRNA improves the suppressive effects of myricetin on non-small cell lung cancer (NSCLC). Song Y; Zhou B; Du X; Wang Y; Zhang J; Ai Y; Xia Z; Zhao G Biomed Pharmacother; 2020 May; 125():109561. PubMed ID: 32106385 [TBL] [Abstract][Full Text] [Related]
19. DNA-Hybrid-Gated Photothermal Mesoporous Silica Nanoparticles for NIR-Responsive and Aptamer-Targeted Drug Delivery. Zhang Y; Hou Z; Ge Y; Deng K; Liu B; Li X; Li Q; Cheng Z; Ma P; Li C; Lin J ACS Appl Mater Interfaces; 2015 Sep; 7(37):20696-706. PubMed ID: 26325285 [TBL] [Abstract][Full Text] [Related]
20. Hydroxylated Mesoporous Nanosilica Coated by Polyethylenimine Coupled with Gadolinium and Folic Acid: A Tumor-Targeted T(1) Magnetic Resonance Contrast Agent and Drug Delivery System. Zhang G; Gao J; Qian J; Zhang L; Zheng K; Zhong K; Cai D; Zhang X; Wu Z ACS Appl Mater Interfaces; 2015 Jul; 7(26):14192-200. PubMed ID: 26084052 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]